Systems Pharmacology
Authors:
- 15 July 2010
- journal article
- review article
- Published by Wiley in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
- Vol. 77 (4) , 333-344
Abstract
We examine how physiology and pathophysiology are studied from a systems perspective, using high‐throughput experiments and computational analysis of regulatory networks. We describe the integration of these analyses with pharmacology, which leads to new understanding of drug action and enables drug discovery for complex diseases. Network studies of drug‐target relationships can serve as an indication on the general trends in the approved drugs and the drug‐discovery progress. There is a growing number of targeted therapies approved and in the pipeline, which meets a new set of problems with efficacy and adverse effects. The pitfalls of these mechanistically based drugs are described, along with how a systems view of drug action is increasingly important to uncover intricate signaling mechanisms that play an important part in drug action, resistance mechanisms, and off‐target effects. Computational methodologies enable the classification of drugs according to their structures and to which proteins they bind. Recent studies have combined the structural analyses with analysis of regulatory networks to make predictions about the therapeutic effects of drugs for complex diseases and possible off‐target effects. Mt Sinai J Med 77:333–344, 2010. © 2010 Mount Sinai School of MedicineKeywords
This publication has 60 references indexed in Scilit:
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growthNature, 2010
- Why We Need Quantitative Dynamic ModelsScience Signaling, 2009
- Identifying the proteins to which small-molecule probes and drugs bind in cellsProceedings of the National Academy of Sciences, 2009
- Global and Site-Specific Quantitative Phosphoproteomics: Principles and ApplicationsAnnual Review of Pharmacology and Toxicology, 2009
- Predicting druggable binding sites at the protein–protein interfaceDrug Discovery Today, 2009
- Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug DiscoveryJournal of Medicinal Chemistry, 2008
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerJournal of Clinical Investigation, 2008
- BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf ProteinsCancer Research, 2008
- Drug Target Identification Using Side-Effect SimilarityScience, 2008
- Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progressionMolecular Systems Biology, 2008